Childhood Obesity

Metabolic Diseases
0
Pipeline Programs
4
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
2 programs
Auxilie® Immuplus, Envicon Medical, Verona, ItalyN/A1 trial
standardized mixed mealN/A1 trial
Active Trials
NCT04723849Completed48Est. Jul 2020
NCT01502826Unknown40Est. Dec 2013
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
2 programs
Chronic care multidisciplinary intervention of childhood obesityN/A1 trial
Food and NutritionN/A1 trial
Active Trials
NCT00823277Completed517Est. Aug 2012
NCT05940675Completed1,372Est. Jun 2025
Alliance Pharmaceuticals
1 program
H2GO!N/A1 trial
Active Trials
NCT04265794Active Not Recruiting824Est. May 2026
CH
Cardinal HealthOH - Dublin
1 program
Simple SuppersN/A1 trial
Active Trials
NCT02923050Completed223Est. Jul 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskFood and Nutrition
Alliance PharmaceuticalsH2GO!
Verona PharmaAuxilie® Immuplus, Envicon Medical, Verona, Italy
Cardinal HealthSimple Suppers
Verona Pharmastandardized mixed meal
Novo NordiskChronic care multidisciplinary intervention of childhood obesity

Clinical Trials (6)

Total enrollment: 3,024 patients across 6 trials

NCT05940675Novo NordiskFood and Nutrition

Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention

Start: Aug 2023Est. completion: Jun 20251,372 patients
N/ACompleted
NCT04265794Alliance PharmaceuticalsH2GO!

A Cluster Randomized Trial of the H2GO! Program

Start: Oct 2020Est. completion: May 2026824 patients
N/AActive Not Recruiting
NCT04723849Verona PharmaAuxilie® Immuplus, Envicon Medical, Verona, Italy

Efficacy Evaluation of a Mixed Compound of Antioxidants in Terms of Endothelium Damage/Function in Pediatric Subjects With Obesity.

Start: Feb 2019Est. completion: Jul 202048 patients
N/ACompleted
NCT02923050Cardinal HealthSimple Suppers

Simple Suppers Scale-up (S3)

Start: Jan 2015Est. completion: Jul 2016223 patients
N/ACompleted
NCT01502826Verona Pharmastandardized mixed meal

Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity

Start: Feb 2012Est. completion: Dec 201340 patients
N/AUnknown
NCT00823277Novo NordiskChronic care multidisciplinary intervention of childhood obesity

Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight

Start: Jan 2009Est. completion: Aug 2012517 patients
N/ACompleted

Related Jobs in Metabolic Diseases

Principal Product Engineer

Medtronic
North Haven, Connecticut, United States of America
Yesterday
$120K - $180K/yr

Obesity Commercial Lead (Pre-Launch), ICO

Pfizer
United Kingdom - Walton Oaks; Europe - Any Pfizer Site
Yesterday

Vice President, Head of Financial Planning and Analysis

NewAmsterdam Pharma
Remote
Yesterday

Senior Product Manager - Body Composition

GE HealthCare
Remote
2d ago
$150K - $224K/yr

Medical Science Liaison - Obesity - MN, IA, WI

Amgen
Minnesota - Minneapolis, US
2d ago

Senior Medical Science Liaison - Obesity - CO, NE, AZ, NM, UT

Amgen
Colorado - Denver, US
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Diabetes(750)Diabetes Mellitus, Type 2(556)Obesity(260)Type 2 Diabetes(216)Type 2 Diabetes Mellitus(211)Diabetes Mellitus(137)Diabetes Mellitus, Type 1(106)Type 1 Diabetes Mellitus(55)Type 1 Diabetes(53)Dyslipidemia(48)